Atlas Trials

Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia

Clinical trial NCT01431092 · COMPLETED

Trial details

NCT number
NCT01431092
Sponsor
Lone Baandrup
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderBipolar Affective Disorder
Start date
2011-10-01
Primary completion
2014-06-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.